硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 RETN 抗体对
试剂盒

抗人 RETN 抗体对

01AB01579

Resistin (RETN) is a cysteine-rich, secreted peptide hormone primarily expressed by immune cells such as monocytes and macrophages in humans, characterized by a unique multimeric structure with a C-terminal beta-sandwich "head" domain and an N-terminal alpha-helical "tail" segment. Functionally, resistin acts as a potent proinflammatory cytokine, stimulating the production of cytokines including IL-6, IL-1β, and TNF-α through activation of signaling pathways involving TLR4 and CAP1 receptors, and upregulating adhesion molecules in endothelial cells, thereby promoting vascular inflammation and smooth muscle cell proliferation. Beyond its inflammatory role, resistin exhibits direct antimicrobial activity by damaging bacterial membranes and modulates immune responses by recruiting and activating immune cells. Clinically, resistin has been implicated in the pathogenesis of several diseases: it is associated with insulin resistance and type 2 diabetes, and elevated levels are predictive of coronary artery disease, cardiovascular mortality, atherosclerosis, and inflammatory conditions such as arthritis.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
RETN
基因别名
FIZZ3; HXCP1; RSTN
蛋白别名
resistin; RETN
UniProt
Q9HD89
物种
Human

产品详情

靶点名称
RETN
蛋白名称
resistin
蛋白别名
Resistin; Adipose tissue-specific secretory factor; ADSF; C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein; Cysteine-rich secreted protein A12-alpha-like 2; Cysteine-rich secreted protein FIZZ3
靶点基因名
RETN
基因别名
FIZZ3; HXCP1; RSTN
UniProt
Q9HD89
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Resistin (RETN) is a cysteine-rich, secreted peptide hormone primarily expressed by immune cells such as monocytes and macrophages in humans, characterized by a unique multimeric structure with a C-terminal beta-sandwich "head" domain and an N-terminal alpha-helical "tail" segment. Functionally, resistin acts as a potent proinflammatory cytokine, stimulating the production of cytokines including IL-6, IL-1β, and TNF-α through activation of signaling pathways involving TLR4 and CAP1 receptors, and upregulating adhesion molecules in endothelial cells, thereby promoting vascular inflammation and smooth muscle cell proliferation. Beyond its inflammatory role, resistin exhibits direct antimicrobial activity by damaging bacterial membranes and modulates immune responses by recruiting and activating immune cells. Clinically, resistin has been implicated in the pathogenesis of several diseases: it is associated with insulin resistance and type 2 diabetes, and elevated levels are predictive of coronary artery disease, cardiovascular mortality, atherosclerosis, and inflammatory conditions such as arthritis.